Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients
Not Applicable
- Conditions
- Cardiomyopathy
- Interventions
- Device: echocardiography
- Registration Number
- NCT02917395
- Lead Sponsor
- Rabin Medical Center
- Brief Summary
Population study- patients with obstructive hypertrophic cardiomyopathy that are treated with disopyramide.
Tow echo examination, few hours apart, that includes strain rate will be done to each patient. The first, after taking the regular medical treatment excluding disopyramide and the last one after taking the disopyramide.
- Detailed Description
Tow echo examination, few hours apart, that includes strain rate will be done to each patient. The first, after taking the regular medical treatment excluding disopyramide and the last one after taking the disopyramide.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- hypertrophic cardiomyopathy that treated with disopyramid
Exclusion Criteria
- pregnancy
- pacemaker
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description echo echocardiography Population study- patients with obstructive hypertrophic cardiomyopathy that are treated with disopyramide. Tow echo examination, few hours apart, that includes strain rate will be done to each patient. The first, after taking the regular medical treatment excluding disopyramide and the last one after taking the disopyramide.
- Primary Outcome Measures
Name Time Method Tow echo examination, few hours apart, that includes strain rate will be done to each patient. The first, after taking the regular medical treatment excluding disopyramide and the last one after taking the disopyramide 2-3 hours
- Secondary Outcome Measures
Name Time Method